Feb 07–10, 2028 | Keystone Resort, Keystone, CO, United States
Scientific Organizers:
David Komander, J. Wade W Harper, and Sonja Lorenz
-
Scientific Organizers: David Komander, J. Wade W Harper, and Sonja Lorenz
David Komander
Walter and Eliza Hall Institute of Medical Research
J. Wade W Harper, PhD
Harvard Medical School
Sonja Lorenz, PhD
Max Planck Institute for Multidisciplinary Sciences
Important Deadlines
Meeting Summary
Ubiquitin and ubiquitin-like proteins (UBLs) regulate virtually every aspect of eukaryotic cell biology, and their dysfunction is linked to diseases such as cancer, neurodegeneration, and immune disorders. Despite decades of progress, critical gaps remain in understanding how ubiquitin signals are encoded, decoded, and co-opted in disease.
This Keystone Symposia conference on Ubiquitin: New Frontiers in Signaling and Cellular Regulation will explore themes such as (1) new frontiers in ubiquitin signaling, (2) UBLs, (3) ubiquitination beyond protein substrates, (4) organelle dynamics, (5) emerging tools and methodologies, and (6) insights from animal model systems. Attendees will gain exposure to field-defining discoveries, emerging technologies, and translational frameworks that are reshaping how the field thinks about proteostasis and induced proximity therapies. Interactive sessions and strong industry participation will make this a pivotal forum for scientists seeking to shape the next generation of investigators working at the interface of cell biology and therapeutics of the ubiquitin system.
The conference will convene biochemists, cell biologists, structural scientists, chemical biologists, and clinician-scientists thereby bridging basic and translational communities at a moment when mechanistic discoveries are being rapidly converted into therapeutic opportunity. Held jointly with the Keystone Symposia conference on Induced Proximity: Emerging Technologies and Clinical Translation, joint sessions focused on targeted protein degradation will create rare opportunities for basic scientists and drug developers to align priorities and forge new collaborations.
The ubiquitin field is undergoing a conceptual expansion into non-protein substrates, organelle quality control, and signaling principles across the broader UBL family—research priorities that are not integrated in any other current meeting. Unlike existing meetings that focus narrowly on ubiquitin pathway structural mechanisms, this conference will fuse mechanistic studies with new and emerging biological systems to generate synergy across the ubiquitin landscape. The timeliness of this conference is compelling and offers researchers an unparalleled scientific and strategic opportunity to chart new directions and position their work at the leading edge of this transformation.
Unique Career Development Opportunities
This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives
SPECIAL RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR SPONSOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
KEYSTONE SYMPOSIA THANKS OUR MEETING EXHIBITOR(S):
KEYSTONE SYMPOSIA THANKS THESE DONOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
THESE COMPANIES HAVE GENEROUSLY AGREED TO COVER THE EXPENSES OF THEIR EMPLOYEES WHO ARE SPEAKING AT THIS MEETING:
GRANT RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS
Subscribe for Updates